Concepedia

Thomas O’Brien

TO

12

Publications

597

Citations

12

H-Index

1980

Active since

Affiliations

Pfizer (United States)(Current)

Instituto de Salud Carlos III

National Cancer Center of Georgia

Centro de Investigación Biomédica en Red de Cáncer

Hospital Universitari i Politècnic La Fe

Thomas O’Brien is an author at Pfizer (United States) specializing in medicine, gastroenterology, and surgery.

ORCID

Top concepts

Publications per year

1980–2024

12

Publications

12

Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome

Mounira Habli, Thomas O’Brien, Elizabeth Nowack et al. · American Journal of Obstetrics and Gynecology · 2008 · 186 citations

, , +3

Lower esophageal sphincter pressure (LESP) and esophageal function in obese humans.

Thomas O’Brien · PubMed · 1980 · 83 citations

, , +15

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer

Ian E. Krop, Vandana G. Abramson, Marco Colleoni et al. · Clinical Cancer Research · 2020 · 64 citations · Full text

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

Michael Heuser, B. Douglas Smith, Walter Fiedler et al. · Annals of Hematology · 2021 · 52 citations · Full text

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

Jörge E. Cortes, Florian H. Heidel, Walter Fiedler et al. · Journal of Hematology & Oncology · 2020 · 36 citations · Full text

Rows per page

1–5 of 12